Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations
Clicks: 289
ID: 9906
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Popular Article
69.4
/100
287 views
234 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Lymphatic malformations are abnormalities that arise in the developing lymphatic system, most frequently presenting in the head and neck. They are typically treated with sclerotherapy, laser therapy, or surgery for localized lesions. Sirolimus, an inhibitor of the mammalian target of rapamycin, is a relatively new medical therapy for the treatment of vascular malformations. This case report presents the improvements and complications seen in a female infant who was diagnosed with a large lymphatic malformation on prenatal ultrasound and has been treated with sirolimus during the first 9 months of life.
| Reference Key |
steven2019sirolimuscase
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Curry, Steven;Logeman, Andrew;Jones, Dwight;Curry, Steven;Logeman, Andrew;Jones, Dwight; |
| Journal | case reports in otolaryngology |
| Year | 2019 |
| DOI |
10.1155/2019/2076798
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.